Damage to the central nervous system (CNS) causes damage to neurons. This damage can result in the complete death of neurons, or in them becoming disconnected from their inputs or target structures due to disruption of axons. The main reason why damage to the human CNS is so disastrous and disabling is that axons will not in general regenerate in the mammalian brain, and neurons once lost are not replaced. In order, therefore, to repair the CNS, techniques will have to be developed to replace dead neurons, and induce axon regrowth. Central to the technologies necessary for brain repair is the ability to induce and control the growth of axons, since in a damaged brain both surviving and newly implanted neurons must grow axons to make or remake appropriate synaptic con nections. Worthwhile treatments, however, do not necessarily require the repair of all the damaged circuits in the CNS, it may be possible to substantially improve the function of patients with relatively few reconnected axons '" if those axons are ones which mediate par ticularly important behaviours, such as respiration, bladder control, or hand and arm movements.
an animal, and producing axons which have to grow through the optic nerve to the brain.6,7 Why have we lost this useful repair function? One specific reason may be due to evolutionary changes in the properties of oligodendrocytes, but in general it is interesting and possibly significant that the loss of regeneration in the eNS in the vertebrates coincides with the loss of the ability to regenerate other body parts.
Axolotls, for instance, will regenerate whole limbs if they are removed as well as axons in the eNS. 8,9 Adult frogs, however, cannot regenerate limbs, and neither can they regenerate most of the axons of their eNS, although tadpoles can do both.
The ability to regenerate cannot be of much evolutionary benefit, so it is theoreti cally possible that some chance genetic change could have led to its loss. It is also conceivable that some benefit accrues from restricting the regenerative ability of animals, although it is hard to see quite what that benefit might be. However, when one starts to look at the reasons why axons will not regenerate, and why limbs will not regrow, it is hard to discern any single basic cellular function whose loss might be responsible for the lack of regenerative ability. Indeed, when one exam ines the reasons for the failure of axon regeneration in the eNS, there seem to be three, apparently disconnected mechanisms which are responsible. These are: (1) the decrease in the vigour of axon growth from neurons as they become mature; (2) the inhibitory nature of oligodendrocytes and (3) the relative impenetrability of astrocytic tissues.
Developmental changes in the vigour of axon growth and regeneration
The neuron usually goes through two main phases in its existence. First it has to migrate to its correct position, and produce an axon which has to grow accurately through the complex terrain of the developing nervous system to form the right connections. If the neuron lives through the crisis of neuronal cell death, it then settles down to a second very different function, that of processing and transmit ting information. This second phase does not call for axon growth in the sense of active elongation led by a growth cone, although the axon may have to stretch as the organism grows. All that is normally required is some ability to form and ret ract connections at the target neurons, in order to subserve the processes of neuro nal plasticity. To some extent each neuron seems to possess a programme which tells it how far its axons need to grow during developrrient. This is reflected both in rate of axonal growth, and in the actual length of processes. Thus if a variety of neurons are removed from an embryo during their normal period of axon growth, and are then examined in tissue culture, their rate of axon outgrowth correlates well with the distance between the neuron and its normal target. 1 0 That there is a programme which determines length of outgrowth is shown by cross species trans plant experiments, in which neurons from large animals (humans) are implanted into smaller ones (rats). Embryonic human striatal neurons have been implanted into adult rats, and grow their axons for a very much greater distance than the equivalent embryonic rat cells implanted into the same site. II In view of the developmental changes in neuronal function which come with maturity, and the finishing of the normal axonal growth programme, it is perhaps surprising that any adult axons are able to regenerate, but in fact more or less all axons do retain some regenerative ability into adulthood. However, regeneration from adult neurons is very much less vigorous than axon outgrowth from the same neurons examined There appear to be three main reasons why axons will not regrow in the eNS; the inhibitory factors on the surface of oligodendrocytes, the relative impenetrabil ity of astrocytes, and the declining vigour of axon regeneration with age. This leads to the practical question of how many of these factors will have to be dealt with before axon regeneration in the eNS becomes a reality. Present evidence suggests that it is not sufficient just to remove one type of inhibition. The inhibitory effect of oligodendrocytes has been neutralised in animals by treating them with anti bodies which block the two inhibitory molecules, and these animals exhibit consid erably more regeneration than normal when the spinal cord is lesioned, but not enough to restore lost function.36 Replacement of adult neurons with embryonic ones also helps, but is not in itself sufficient. If embryonic neurons are placed in the adult brain, their axons grow very much more than the equivalent adult neurons, but they are still not able to cross significant distances to an appropriate target area; they only grow when the neurons are transplanted within a region of target neurons. 12 At present there is no way of making it easy for axons to penetrate astrocytes, so the effects of removing this inhibitory factor by itself are not known.
If more than one inhibitory effect must be eliminated, must it be all three, or is it enough to eliminate two? When a peripheral nerve graft is inserted into the CNS, the inhibitory influences of both astrocytes and oligodendrocytes are removed. The result is that mature neurons can rege�erate their axons well within the Schwann cell environment, suggesting that removal of the two glial effects may in itself be sufficient. 25 Similarly, it is conceivable that the combination of embryonic neurons and removal of just one of the glial inhibitory effects might lead to successful axon growth. It is possible, therefore, that a combination of two treatments might be sufficient to greatly enhance the repair processes in the CNS following injury.
